Publicaciones en colaboración con investigadores/as de Institució Catalana de Recerca i Estudis Avançats (23)

2022

  1. Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

    Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258

  2. Erratum: Whole-brain dynamics in aging: disruptions in functional connectivity and the role of the rich club (Cerebral Cortex (2021) 31 (2466-2481) DOI: 10.1093/cercor/bhaa367)

    Cerebral Cortex

  3. Microbiota alterations in proline metabolism impact depression

    Cell Metabolism, Vol. 34, Núm. 5, pp. 681-701.e10

  4. Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model

    Neuropathology and Applied Neurobiology, Vol. 48, Núm. 1

2021

  1. Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 4, pp. 544-563

  2. Whole-Brain Dynamics in Aging: Disruptions in Functional Connectivity and the Role of the Rich Club

    Cerebral Cortex, Vol. 31, Núm. 5, pp. 2466-2481

2020

  1. The Aging Imageomics Study: rationale, design and baseline characteristics of the study population

    Mechanisms of Ageing and Development, Vol. 189

2019

  1. Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

    Neurotherapeutics, Vol. 16, Núm. 4, pp. 1167-1182

2018

  1. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy

    EMBO Molecular Medicine, Vol. 10, Núm. 8

2017

  1. Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance

    Aging Cell, Vol. 16, Núm. 6, pp. 1404-1413

2016

  1. Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 4, pp. 526-535

2015

  1. Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy

    Cell Death and Differentiation, Vol. 22, Núm. 11, pp. 1742-1753

  2. Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy

    Human Molecular Genetics, Vol. 24, Núm. 24, pp. 6861-6876

  3. Deregulation of purine metabolism in Alzheimer's disease

    Neurobiology of Aging, Vol. 36, Núm. 1, pp. 68-80

  4. Neuroinflammatory signals in alzheimer disease and APP/PS1 transgenic mice: Correlations with plaques, tangles, and oligomeric species

    Journal of Neuropathology and Experimental Neurology, Vol. 74, Núm. 4, pp. 319-344

2013

  1. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy

    Human Molecular Genetics, Vol. 22, Núm. 16, pp. 3296-3305

  2. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy

    Brain, Vol. 136, Núm. 8, pp. 2432-2443

2012

  1. Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease

    Brain Pathology, Vol. 22, Núm. 5, pp. 636-653

  2. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: A paradigm for multifactorial neurodegenerative diseases?

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1822, Núm. 9, pp. 1475-1488

2011

  1. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy

    Annals of Neurology, Vol. 70, Núm. 1, pp. 84-92